News Snapshot:
AstraZeneca signs first COVID-19 vaccine supply deal with Chinese company Roxanne Liu and Tony Munroe , • August 6, 2020 FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York More By Roxanne Liu and Tony Munroe BEIJING (Reuters) - Shenzhen Kangtai Biological Products will produce AstraZeneca Plc's potential COVID-19 vaccine in mainland China, the British drugmaker said on Thursday, its first deal to supply one of the world's most populous countries. To meet market demand in China, Shenzhen Kangtai will ensure it has annual production capacity...
